netFormulary NHS
Shropshire and Telford Local Health Economy
Shropshire, Telford and Wrekin CCG
Shrewsbury and Telford Hospitals NHS Trust
Robert Jones & Agnes Hunt Orthopaedic Hospital NHS Foundation Trust
Shropshire Community Health NHS Trust
 Search
 Formulary Chapter 8: Malignant disease and immunosuppression - Full Section
Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
08.01 Cytotoxic drugs (2,1)
Drugs for cytotoxic-induced side-effects (4,0)
08.01.01 Alkylating drugs (10,2)
08.01.02 Anthracyclines and other cytotoxic antibiotics (8,1)
08.01.03 Antimetabolites (13,2)
08.01.04 Vinca alkaloids and etoposide (4,1)
08.01.05 Other antineoplastic drugs (40,5)
Arsenic trioxide (1,0)
Bevacizumab (1,0)
Bortezomib (1,0)
Brentuximab vedotin (1,0)
Cetuximab (1,0)
Crisantaspase (1,0)
Dacarbazine and Temozolomide (2,0)
Erlotinib (1,0)
Hydroxycarbamide (1,0)
Ipilimumab (1,0)
Pentostatin (1,0)
Platinum compounds (4,0)
Procarbazine (1,0)
Protein kinase inhibitors (17,3)
Taxanes (3,0)
Topoisomerase I inhibitors (2,0)
Trabectedin (1,0)
Trastuzumab (4,0)
Tretinoin (1,0)
Vismodegib (0,1)
08.02 Drugs affecting the immune response (2,2)
08.02.01 Antiproliferative immunosuppressants (3,0)
08.02.02 Corticosteroids and other immunosuppressants (9,4)
08.02.03 Anti-lymphocyte monoclonal antibodies (6,1)
08.02.04 Other immunomodulating drugs (11,7)
Interferon Alfa (5,0)
Interferon beta (5,0)
Aldesleukin (2,1)
Dimethyl fumarate (1,0)
Glatiramer acetate (1,0)
Mifamurtide (1,0)
Natalizumab (1,0)
08.03.01 Oestrogens (1,0)
08.03.02 Progestogens (2,0)
08.03.04.01 Breast cancer (7,0)
08.03.04.02 Prostate cancer and gonadorelin analogues (0,1)
Gonadorelin analogues (1,0)
Anti-androgens (12,0)
08.03.04.03 Somatostatin analogues (4,0)
netFormulary